What Dependence Looks Like With Ketamine

The short answer is yes, ketamine can be addictive, but the picture looks different than what you might expect from alcohol or opioids. There is no neat withdrawal syndrome to point to, no detox timeline you can circle on a calendar. What clinicians watch for instead is a cluster of behaviors and body changes that, taken together, point to a problem.

Heavy ketamine use is linked to tolerance, craving, and continued use despite real harm, alongside memory problems, depression, anxiety, psychosis, and bladder injury ¹. That last word, “despite,” is the one that matters most. If you have noticed that the dose you used to take barely registers now, that you think about your next bump in the middle of work, or that you keep using even though your bladder hurts or your mood is sliding, those are the signs the literature is describing.

The lived picture, drawn from a primary care review, includes cravings and physical discomfort when people try to quit, and at high doses the profound detachment from reality called the k-hole ¹³. Some people chase that detachment on purpose. Others arrive at it by accident after the dose that used to feel manageable stops being enough.

If any of this is starting to sound familiar, you are not failing some character test. You are noticing something real about a drug that does, in fact, have addictive potential, even if its withdrawal looks fuzzier than the textbook examples ¹³. Noticing is the first useful thing.

The Supervised-Treatment Question: Can Spravato Patients Become Dependent?

If you are receiving esketamine for treatment-resistant depression, you have probably wondered this in the parking lot after a session. It is a fair question, and the honest answer is that the risk exists but the setting is built to keep it small.

A 2025 review looking specifically at whether therapeutic ketamine for depression triggers tolerance or dependence found that, across the included studies, four patients showed clear signs of tolerance or dependence while most did not ². Four patients is a narrow signal in a heterogeneous body of research, not a population rate. It tells you the phenomenon is possible, not that it is likely for any given person on a clinic schedule.

The structural differences between supervised esketamine and non-medical ketamine are worth seeing side by side. Spravato is a Schedule III drug dispensed only through certified healthcare settings under a REMS program, with patients monitored on site for at least two hours after each dose because of sedation, dissociation, and respiratory depression risks ¹⁰. The VA’s national protocol layers in REMS enrollment, restricted access, and structured tracking of abuse and misuse signals ¹¹. Non-medical ketamine has none of that: no certified setting, no clinician watching the dose, no observation period, no record of how often you used last month.

That distinction is the point. If you are on Spravato, the question to bring to your prescriber is not whether to stop, but how dependence is being monitored across your treatment course.

Why People With Mood and Trauma Histories End Up Here

There is a reason ketamine finds people who are already carrying something heavy. If you live with depression, the world can feel like it is happening behind glass. If you live with PTSD, your body keeps score in ways that do not switch off when the day ends. Anxiety hums underneath both. Ketamine, especially at higher doses, offers a temporary off-switch for all of it. The detachment that worries clinicians is, for some users, exactly the point.

That overlap is not just anecdotal. A 2025 study found that ketamine use was more common among people in substance use treatment than those not in treatment, and that association persisted across several SUD categories ¹⁴. The authors are careful, and so should you be: this is association, not causation. It does not mean ketamine caused the other problems, or that everyone in treatment is using ketamine. It does suggest that ketamine exposure tends to cluster with other substance use and the kinds of complicated histories that bring people into care.

If you have used ketamine to quiet a panic spiral, to dull a trauma memory that will not stay buried, or to feel anything at all on a flat depressive day, you are not unusual. You are doing what humans do when a substance happens to match the shape of a wound. Recognizing that pattern is not a confession. It is information you can finally do something with.

The Paradox: A Treatment for Conditions It Can Also Worsen

Here is the part that makes ketamine genuinely confusing. A 2024 meta-analysis found supportive evidence for ketamine in PTSD, OCD, and alcohol use disorders, though the number of randomized controlled trials remains small ⁶. Other 2025 reviews report preliminary efficacy signals for ketamine in alcohol, cocaine, opioid, and cannabis use disorders, with the consistent caveat of small samples and limited randomized data ^{7, 8}. Some evidence even suggests ketamine infusion paired with psychotherapy may help promote abstinence in alcohol and cocaine use ¹⁵. The same drug you may be worried about is being studied as a treatment for the conditions you may be self-medicating.

And yet. Heavy ketamine use is linked to depression, anxiety, and psychosis ¹. Common adverse effects, even in clinical settings, include dissociation, anxiety, and confusion ¹². A drug that lifts depression in a monitored two-hour session can deepen it when used alone at 2 a.m. The dose, the setting, the frequency, and the person all matter.

Behavioral and Psychological Patterns

The warning signs that actually matter are not the dramatic ones. They are quiet, easy to explain away, and they tend to show up in your calendar before they show up in your body.

Watch for the dose that used to feel like enough. Tolerance is one of the clearest behavioral markers, and it often gets reframed as a tolerance “to” the experience rather than a problem with it ¹. Watch for the rearranging. If you have moved appointments, skipped meals, or cut a conversation short because you wanted to use sooner, that is craving doing what craving does ¹³. Watch for the using alone. Use that used to be social, occasional, or tied to a specific setting and is now solo and routine is a pattern worth naming out loud.

Watch for the mood drift in the wrong direction. Dissociation, anxiety, and confusion are common even in clinical settings ¹², and heavy non-medical use is linked to worsening depression, anxiety, and in some cases psychosis ¹. If the thing you started using to feel less depressed has been making you feel more depressed, that is information.

And watch for the memory gaps. Lost hours, lost conversations, lost where-did-I-put-this moments stacking up week over week deserve attention. Noticing any of this does not mean you have failed. It means you are paying enough attention to do something about it.

Bladder Pain and Other Physical Signals

If your bladder hurts, your body is telling you something the rest of the literature has been slow to say plainly. Ketamine-induced uropathy is one of the most distinctive harms of chronic use, and it can show up well before anyone would describe their use as out of control ¹.

The early signals are easy to dismiss. You are going to the bathroom more often than your friends. You wake up at night to pee when you never used to. There is a burning sensation that comes and goes. The urgency feels disproportionate to how much liquid you actually drank. Over time, some people develop blood in the urine, persistent pelvic pain, and a bladder that has physically shrunk in capacity. National guidelines for ketamine cystitis describe available therapies as limited and non-specific, with abstinence remaining central to recovery ⁴. There is no pill that fixes this while you keep using.

Even under medical supervision, urinary symptoms are not zero. A 2025 systematic review of patients receiving ketamine for psychiatric conditions found urological symptoms reported in 0% to 24.5% of patients across studies, usually mild to moderate, with only 15% of those studies rated as low risk of bias ⁵. The honest reading of that range is wide uncertainty, not a clean rate you can plan around.

Other physical signals worth noticing: elevated blood pressure, nausea, and lingering confusion after use are common adverse effects ¹². If you are using outside a monitored setting and any of these are stacking up, that is the body asking for a different plan. Bladder symptoms in particular tend to improve with stopping, and they tend to get worse without it ⁴.

Treating the Substance Use and the Psychiatric Condition Together

If you have read this far, you already know the trap. Stopping ketamine without treating the depression, PTSD, or anxiety underneath leaves the original pain where it has always been. Treating the psychiatric condition without addressing the substance use leaves the escape hatch open, and that hatch tends to get used on the hard days. Dual-diagnosis care exists because pulling these two threads at the same time is the only way most people actually get free of either.

The research keeps pointing in this direction even when it does not mean to. The 2025 association study found ketamine use clustered with other substance use in treatment populations, which means people walking into treatment for one thing often have ketamine in the mix too ¹⁴. The 2024 pharmacological review made clear that there is no strong medication protocol for ketamine use disorder on its own ³. And even the studies looking at ketamine as a possible therapy for alcohol or cocaine use disorders found their best signals when ketamine infusion was paired with psychotherapy, not given as a standalone fix ¹⁵. The pattern is consistent: medication without therapy underperforms, and therapy without addressing the substance underperforms.

What integrated care looks like in practice is less mysterious than the label suggests. The same clinical team coordinates psychiatric medication, trauma-focused therapy like EMDR or CBT, and substance use support. Your prescriber knows about your ketamine history. Your therapist knows what your medications are doing. Nobody is asking you to repeat the same intake story to four different people who never compare notes. That coordination matters because relapse and symptom flares often share triggers, and a team that sees both can respond to both.

What to Ask Your Prescriber or a Treatment Program

Walking into this conversation can feel impossible, especially if you have not been fully honest about your use yet. Bring questions instead of confessions. Questions give you somewhere to stand.

If you are on Spravato, ask your prescriber how dependence is being tracked across your treatment course, what would prompt a change in your dosing schedule, and how your depression scores are trending alongside your between-session cravings. The REMS framework already builds in monitoring during sessions ^{10, 11}, but the between-session picture is where you need to advocate for yourself.

If you are looking at a treatment program, the questions get more specific. Does the program treat psychiatric conditions and substance use under one clinical team, or refer them out separately? What therapies are offered for trauma and mood symptoms, not just for substance use? How are bladder symptoms handled medically while you stabilize, given that abstinence is central to cystitis recovery and the available therapies are limited ⁴? What does aftercare look like at three months, six months, a year?

You do not need perfect answers from yourself before you make the call. Noticing was the first step. Asking is the next one. If you are in Ohio and want a program built specifically around treating substance use and co-occurring mental health conditions in the same place, Arrow Passage Recovery is one option worth a conversation.